Recombinant Cynomolgus Monkey uPAR Fc Chimera Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 10972-UK

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
10972-UK-100
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

HEK293

Accession #

Q9GK78.1

Conjugate

Unconjugated

Applications

Bioactivity

View all uPAR Proteins and Enzymes »

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived cynomolgus monkey uPAR protein
Cynomolgus Monkey UPAR
(Leu23-Arg303)
Accession # Q9GK78.1		 IEGRMD Human IgG1 Fc
(Pro100-Lys330)
N-terminus C-terminus

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Leu23

Predicted Molecular Mass

58 kDa

SDS-PAGE

75-85 kDa, under reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Cynomolgus Monkey uPAR Fc Chimera is immobilized at 1.00 ug/mL (100 µL/well), Recombinant Human u-Plasminogen Activator/Urokinase   (Catalog # 1310-SE) binds with an ED50 of 15.0-90.0 ng/mL.

Scientific Data Images for Recombinant Cynomolgus Monkey uPAR Fc Chimera Protein, CF

Recombinant Cynomolgus Monkey uPAR Fc Chimera Protein Binding Activity.

When Recombinant Cynomolgus Monkey UPAR Fc Chimera (Catalog # 10972-UK) is immobilized at 1.00 μg/mL (100 µL/well), Recombinant Human u-Plasminogen Activator/Urokinase (1310-SE) binds with an ED50 of 15.0-90.0 ng/mL.

Recombinant Cynomolgus Monkey uPAR Fc Chimera Protein SDS-PAGE.

2 μg/lane of Recombinant Cynomolgus Monkey uPAR Fc Chimera (Catalog # 10972-UK) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 75-85 kDa and 150-170 kDa, respectively.

Formulation, Preparation and Storage

10972-UK
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution Reconstitute at 1.00 mg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: uPAR

Urokinase plasminogen activator receptor (uPAR), also known as CD87, is a cysteine-rich cell surface glycoprotein belonging to the Ly6/uPAR (LU) superfamily and is involved in the activation of plasminogen to plasmin (1). Mature uPAR consists of an extracellular domain (ECD) with 3 LU domains (D1, D2, and D3) similar to Ly-6 antigens and snake venom alpha-neurotoxins and a C-terminal glycosyl-phosphatidylinositol (GPI) anchor linked to the last residue of the third LU domain (1-3). The ECD of mature cynomolgus uPAR shares 95% amino acid sequence identity with human uPAR. Posttranslational modification generates several soluble uPAR fragments including uPAR, uPAR DIIDIII, and uPAR DI in human (1-3). The urokinase-type Plasminogen Activator (uPA) is one of two activators that converts the extracellular zymogen plasminogen to plasmin. The binding of uPAR with uPA initiates a proteolytic cascade resulting in the degradation of extracellular matrix components and stimulates tissue remodeling (4). The uPAR/uPA interaction also initiates signal transduction responses resulting in activation of protein tyrosine kinases, gene expression, cell adhesion, and chemotaxis (4). uPAR can interact with integrins to suppress normal integrin adhesive function and promote adhesion to vitronectin through a high affinity vitronectin binding site (5, 6). uPAR expression is limited in normal human tissue but is highly expressed by diverse cancer cells and by non-malignant cells that infiltrate cancers and uPAR expression is associated with poor prognosis and increased risk of metastasis (7). uPAR is considered as a biomarker in many inflammatory diseases including cancer, cardiovascular diseases, chronic kidney diseases and diabetes (6).

References

  1. Blasi, F. and Carmeliet, P. (2002) Nat Rev Mol. Cell Biol 3:932.
  2. Leth, J.M. and Ploug, M. (2021) Front Cell Dev. Biol. 9:732015.
  3. Behrendt, N. et al. (1996) J Biol. Chem. 271:22885.
  4. Mahmood, N. et al. (2018) Front. Oncol. 8:24.
  5. Smith, H. et al. (2010) Nat Rev Mol Cell Biol 11:23.
  6. Desmedt, S. et al. (2017) Crit. Rev. Clin. Lab. Sci. 54:117.
  7. Mazar, A.P. (2008) Clin. Cancer Res. 14:5649.

Long Name

Urokinase-type Plasminogen Activator Receptor

Alternate Names

PLAUR

Entrez Gene IDs

5329 (Human); 18793 (Mouse); 102139334 (Cynomolgus Monkey)

Gene Symbol

PLAUR

UniProt

Q9GK78.1

Additional uPAR Products

Product Documents for Recombinant Cynomolgus Monkey uPAR Fc Chimera Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Cynomolgus Monkey uPAR Fc Chimera Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.